Genetic dilemma: eNOS gene intron 4a/b VNTR polymorphism in sepsis and its clinical features in Turkish children

Turkish Journal of Pediatrics

Volumn 50, Issue 2, 2008, Pages 114-119

  Çelik, Ümit ^a   Yildizdaş, Dinçer ^a   Alhan, Emre ^a   Çelik, Tamer ^a   Attila, Gülen ^a   Sertdemir, Yaşar ^a   Tepe, Tugay ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Acute respiratory distress syndrome; eNOS gene intron 4a b VNTR polymorphism; Mortality; Multiorgan dysfunction syndrome; Sepsis; Septic shock

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOGENESIS; POLYMERASE CHAIN REACTION; SEPSIS; SHOCK; TURKEY (REPUBLIC); VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTIPLE ORGAN FAILURE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 48649088794     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lawler DA. Hormonal response in sepsis. Crit Care Nurs Clin North Am 1994; 6: 265-274.
2. Baier RJ, Loggins J, Yanamandra K, et al. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. J Perinatol 2005; 25: 205-209.
3. O'Dwyer MJ, Dempsey F, Crowley V, et al. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care 2006; 10: 139.
4. Stewart T, Zhang H. Nitric oxide in sepsis. Respir Care 1994; 44: 308-313.
5. Rossaint R, Falke KJ, Lopez FA, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
6. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy. Effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157: 1372-1380.
7. Dusting GJ. Nitric oxide in coronary artery disease, roles in atherosclerosis, myocardial infarction and heart failure. EXS 1996; 76: 33-35.
8. Dusting, GJ. Nitric oxide in cardiovascular disorders. J Vasc Res 1995; 32: 141-143.
9. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
10. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198: 1027-1033.
11. Mardsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
12. Miyahara K, Kawamoto T, Sase K, et al. Cloning and structural characterization of human endothelial nitric oxide synthase gene. Eur J Biochem 1994; 223: 719-726.
13. Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147-3153.
14. Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190-193.
15. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
16. Goldstein B, Giroir B, Randolph A. International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Ped Crit Care Med 2005; 6: 2-8.
17. Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordinition. The Consensus Committee. Intensive Care Med 1994; 20: 225-232.
18. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 11: 1215-1220.
19. Nava E, Palmer RM, Moncada S, et al. The role of nitric oxide in endotoxic shock. Effects of NG-monomethyl-L-arginine. J Cardiovasc Pharmacol 1992; 12: 132-134.
20. Annane D, Sanquer S, Sebille V, et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000; 355: 1143-1148.
21. Rigato O, Salomao R. Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 2003; 19: 113-116.
22. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595.
23. Cotter G, Kaluski E, Blatt A, et al. LNMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000; 101: 1358-1361.
24. Hickling KG. The pressure-volume curve is greatly modified by recruitment. Am J Respir Crit Care Med 1998; 158: 194-202.
25. Dobyns EL, Cornfield DN, Anas NG, et al; Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999; 134: 406-412.
26. Payen D, Vallet B. Results of the French prospective multicentre randomized double-blind placebo-controlled trial of inhaled nitric oxide (NO) in ARDS. Intensive Care Med 1999; 25: 166.